These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 32174452)

  • 1. Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review.
    Liu Y; Liu X; Xie M; Chen Z; He J; Wang Z; Dai J; Cai H
    Respir Med; 2020; 165():105920. PubMed ID: 32174452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
    Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome.
    Zhang Y; Ge Y; Yang H; Chen H; Tian X; Huang Z; Liu S; Lu X; Wang G
    Clin Rheumatol; 2020 Aug; 39(8):2417-2424. PubMed ID: 32144624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China.
    Wang R; Zhao Y; Qi F; Wu X; Wang Y; Xu Y; Wu Y; Zhang N; Hou H; Sun W; Li X; Wei W
    Clin Rheumatol; 2023 Mar; 42(3):703-709. PubMed ID: 36308573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy.
    Sasano H; Hagiwara E; Kitamura H; Enomoto Y; Matsuo N; Baba T; Iso S; Okudela K; Iwasawa T; Sato S; Suzuki Y; Takemura T; Ogura T
    BMC Pulm Med; 2016 Dec; 16(1):168. PubMed ID: 27903248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome.
    Zamora AC; Hoskote SS; Abascal-Bolado B; White D; Cox CW; Ryu JH; Moua T
    Respir Med; 2016 Sep; 118():39-45. PubMed ID: 27578469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics of patients with antisynthetase syndrome and interstitial pulmonary disease].
    Li W; Li J; Xie WM; Ren YH; Dai HP
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(24):1861-1865. PubMed ID: 32575928
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q
    BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome.
    Liu H; Xie S; Liang T; Ma L; Sun H; Dai H; Wang C
    Eur Radiol; 2019 Oct; 29(10):5349-5357. PubMed ID: 30919069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study.
    Baratella E; Marrocchio C; Cifaldi R; Santagiuliana M; Bozzato AM; Crivelli P; Ruaro B; Salton F; Confalonieri M; Cova MA
    Jpn J Radiol; 2021 Jan; 39(1):40-46. PubMed ID: 32876818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies.
    Koreeda Y; Higashimoto I; Yamamoto M; Takahashi M; Kaji K; Fujimoto M; Kuwana M; Fukuda Y
    Intern Med; 2010; 49(5):361-9. PubMed ID: 20190466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
    Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
    J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome.
    Marie I; Josse S; Decaux O; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Hachulla E; Vittecoq O; Menard JF; Jouen F; Dominique S
    Eur J Intern Med; 2013 Jul; 24(5):474-9. PubMed ID: 23375620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
    Shi J; Li S; Yang H; Zhang Y; Peng Q; Lu X; Wang G
    J Rheumatol; 2017 Jul; 44(7):1051-1057. PubMed ID: 28461650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
    Chen F; Wang J; Zhang P; Zuo Y; Ye L; Wang G; Shu X
    Front Immunol; 2022; 13():879266. PubMed ID: 35603153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis.
    Xing X; Li A; Li C
    Respir Med; 2020 Oct; 172():106134. PubMed ID: 32905890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients.
    Váncsa A; Csípo I; Németh J; Dévényi K; Gergely L; Dankó K
    Rheumatol Int; 2009 Jul; 29(9):989-94. PubMed ID: 19266202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease.
    Andersson H; Sem M; Lund MB; Aaløkken TM; Günther A; Walle-Hansen R; Garen T; Molberg Ø
    Rheumatology (Oxford); 2015 Aug; 54(8):1420-8. PubMed ID: 25740830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.
    Fukamatsu H; Hirai Y; Miyake T; Kaji T; Morizane S; Yokoyama E; Hamada T; Oono T; Koyama Y; Norikane S; Iwatsuki K
    J Dermatol; 2019 Oct; 46(10):886-897. PubMed ID: 31418479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review.
    Doyle TJ; Dhillon N; Madan R; Cabral F; Fletcher EA; Koontz DC; Aggarwal R; Osorio JC; Rosas IO; Oddis CV; Dellaripa PF
    J Rheumatol; 2018 Jun; 45(6):841-850. PubMed ID: 29606668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.